The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb’s BMY-N blockbuster cancer drug, Opdivo. Opdivo is part of a class of ...
Hikma said on Monday it was “pleased to have FDA approval to launch this important medicine and to provide broader access and greater affordability for the patients who rely on it”.
Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...
Accelerated approval was based on promising results from the ongoing Phase III BREAKWATER trial. The FDA has granted accelerated approval to Pfizer’s Braftovi (encorafenib) in combination with ...
BRAFTOVI ® (encorafenib) is indicated, in combination with cetuximab and mFOLFOX6, for the treatment of patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, as detected by an ...
US President Joe Biden on Friday agreed to provide US$571.3 million in defense support for Taiwan, the White House said, while the US State Department approved the potential sale of US$265 million in ...
the FDA received 1,516 requests for this designation, and only 587 have been granted. This is in line with previous years, during which around 30-40% of requests have been approved. Dostarlimab ...
Trump had demanded. Carl Hulse Maya C. Miller and Catie Edmondson The Senate approved legislation to avert a federal government shutdown just after a midnight deadline, capping a chaotic week in ...
With an FDA approval for Tryngolza (olezarsen) to treat the rare genetic disorder familial chylomicronemia syndrome (FCS), Ionis Pharmaceuticals enters a new era. While Ionis has gained several ...
Although progression-free survival and overall survival data are not yet available from BREAKWATER, the FDA said that these outcomes will provide the post-marketing confirmatory evidence needed to ...
Ionis Pharmaceuticals on Thursday won Food and Drug Administration approval of a therapy for patients with a rare and deadly genetic disease that impedes the body’s ability to break down fats ...